Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.31 +0.11 (+5.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Rocket Pharmaceuticals (RCKT) Operating Interest Expenses (2015)

Updated

Rocket Pharmaceuticals' Operating Interest Expenses came in at $209,000 for Q1 2015.

Analysis

Rocket Pharmaceuticals (RCKT) Operating Interest Expenses (2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Interest Exp. (Qtr)
1 Eli Lilly 1,143.62 Bn 1,112.20 Bn 19.71 Bn -
2 Johnson & Johnson 635.32 Bn 555.18 Bn 17.30 Bn -
3 AbbVie 501.71 Bn 474.82 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.42 Bn 12.21 Bn -
5 Novartis Ag 300.80 Bn 264.79 Bn 11.24 Bn -
6 Astrazeneca 263.31 Bn 237.00 Bn 12.86 Bn -
7 Amgen 238.70 Bn 194.10 Bn 7.24 Bn -
8 Gilead Sciences 194.80 Bn 169.00 Bn 6.22 Bn -
9 Pfizer 170.88 Bn 117.53 Bn 10.94 Bn -
10 Rocket Pharmaceuticals 248.26 Mn -35.44 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 209,000.00
API Access

Rocket Pharmaceuticals Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-interest-expenses&ticker=RCKT&period=max&api_key=YOUR_API_KEY